# Sleep Outcomes and Multidimensional Sleep Assessment - a Randomized Trial of Dolutegravir- vs Doravirine-based Antiretroviral Therapy in People Living With HIV

> **NCT07673965** · PHASE4 · NOT_YET_RECRUITING · sponsor: **University of Witwatersrand, South Africa** · enrollment: 40 (estimated)

## Conditions studied

- HIV (Human Immunodeficiency Virus)
- Sleep

## Interventions

- **DRUG:** Tenofovir disoproxil fumarate 300mg / Lamivudine 300mg / Doravirine 100mg
- **DRUG:** Tenofovir disoproxil fumarate 300mg / Lamivudine 300mg / Dolutegravir 50mg

## Key facts

- **NCT ID:** NCT07673965
- **Lead sponsor:** University of Witwatersrand, South Africa
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-05
- **Primary completion:** 2027-08-31
- **Final completion:** 2027-11-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07673965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07673965, "Sleep Outcomes and Multidimensional Sleep Assessment - a Randomized Trial of Dolutegravir- vs Doravirine-based Antiretroviral Therapy in People Living With HIV". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07673965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*